10.04.05
The Dow Chemical Company’s Board of Directors has elected Andrew N. Liveris, business group president, performance chemicals, president and COO. William S. Stavropoulos will relinquish his role as president, but will continue as chairman of the board and CEO.
“In selecting Andrew, the board followed a thorough and thoughtful process,” said Harold T. Shapiro, presiding director of the Dow board. “We selected him unanimously after considering his broad and diverse background of international business experience, strong strategic acumen, and demonstrated capacity for leadership, as well as his recognized respect for people and their contributions.”
In addition to focusing on Dow’s action plan for financial recovery, Mr. Liveris also will initially be responsible for reviewing Dow’s long-term strategy and aligning an organizational structure for improving shareholder value.
Mr. Liveris’ 27-year Dow career has spanned manufacturing, sales, marketing, new business development and management. He has worked for Dow in Australia, Thailand, Hong Kong and the U.S. Mr. Liveris has been business group president since April 2000 of the $5.1 billion performance chemicals portfolio.
“In selecting Andrew, the board followed a thorough and thoughtful process,” said Harold T. Shapiro, presiding director of the Dow board. “We selected him unanimously after considering his broad and diverse background of international business experience, strong strategic acumen, and demonstrated capacity for leadership, as well as his recognized respect for people and their contributions.”
In addition to focusing on Dow’s action plan for financial recovery, Mr. Liveris also will initially be responsible for reviewing Dow’s long-term strategy and aligning an organizational structure for improving shareholder value.
Mr. Liveris’ 27-year Dow career has spanned manufacturing, sales, marketing, new business development and management. He has worked for Dow in Australia, Thailand, Hong Kong and the U.S. Mr. Liveris has been business group president since April 2000 of the $5.1 billion performance chemicals portfolio.